Electromed, Inc. (ELMD) Fair Value 2026

ELMD · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

9.0 /10

32 fundamental signals · 10 models active

Value Trap Risk

LOW (28/100)

Quick Summary — As of 2026-08-27, Electromed, Inc. (ELMD) trades at $30.14, versus a $19.59 median fair value across its 10 active models — 35.0% below the current price. QOC: 9.0/10. Value Trap Risk: 28/100 (LOW). 10/13 models active. Within that set, the Bayesian DCF component alone returns $9.00.

Key Facts

Ticker
ELMD
Price
$30.14
Quality Score
9.0/10
Value Trap Risk
28/100
Models Active
10/13
Last Updated
Strength: First Chicago suggests +51.1% upside with 64% confidence
Risk: Majority of models suggest overvaluation

Is Electromed, Inc. (ELMD) Undervalued or Overvalued in 2026?

According to CirclFi’s 10-model valuation engine, Electromed, Inc. (ELMD) appears overvalued as of : the median of 10 independent fair value estimates is $19.59, 35.0% below the current price of $30.14. Estimates range from $9.00 to $50.63. ELMD scores 9.0/10 on fundamental quality and 28/100 on value-trap risk.

For context, the median US equity CirclFi rates trades at an implied -23.7% versus its own 13-model consensus, across 3,801 rated companies as of 2026-08-27. ELMD’s -35.0% gap is wider than that market norm, and the Medical Devices sector median is -43.5%. Full market index →

This verdict compares price to intrinsic value only — it is not a buy or sell rating. For the decision case (bull vs bear arguments, risk factors, peers), read Should You Buy Electromed, Inc. Stock in 2026? →

What Fair Value Does Each Model Give ELMD?

10 Intrinsic Value Models vs. Current Price ($30.14)

Core Models (Unlocked)
Model Fair Value Upside
Intrinsic · High Conviction
 $9.00 -70.1%
Intrinsic · High Conviction
 $11.76 -61.0%
Ensemble · Medium Conviction
 $20.53 -31.9%
Scenario · High Conviction
 $45.55 +51.1%
Unlock the Full Matrix

Access 6 additional models including EROIC Spread, ML-RIV, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 10 Models →

Cancel anytime · No contracts · Instant access

What Is ELMD's Fair Value Range?

Spread across 10 independent models · $9.00 to $50.63

CirclFi's 10 active models place Electromed, Inc. (ELMD) between $9.00 and $50.63 per share, a spread of 212% of the median. The median of that range — $19.59 — is the fair value CirclFi publishes for ELMD, against a current price of $30.14.

Low · Bayesian DCFHigh · Regime Cross
$9.00median $19.59$50.63
Where the range comes from
Most bearish modelBayesian DCF$9.00
Most bullish modelRegime Cross-Sectional$50.63
Model agreement2 bullish · 7 bearishwide

A band this wide is itself the finding. When independent methods land far apart, they are reading a business whose value depends heavily on which lens you apply — volatile earnings, heavy reinvestment, or an asset base that cash-flow and asset-based methods score differently. That disagreement is information: it says the choice of method matters more than usual for ELMD. Treat the median as one reading among several and compare the individual models below before acting.

Every figure above is one model's standalone output on ELMD, not a CirclFi price target. How each model works →

What Is Electromed, Inc. (ELMD) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Electromed, Inc.'s intrinsic value is estimated at a median fair value of $19.59. Trading at $30.14, the stock is approaching fair value or slight overvaluation (implied return of -35.0%), as 7 of 10 models suggest limited further upside. Model dispersion is worth noting: Regime Cross targets $50.63 (+68.0%), versus Bayesian DCF at $9.00 (-70.1%). This +138.1% range highlights the importance of multi-model analysis rather than relying on any single methodology. Among models with highest confidence, Bayesian DCF, EPV lean bearish — adding weight to the bearish side of the thesis.

What Do the Models Say About ELMD?

10 of 13 models are currently active for ELMD. Of these, 3 models suggest upside while 7 models suggest overvaluation. Taken together, their median fair value for ELMD is $19.59 — the figure CirclFi publishes as this stock's fair value. One component of that median, the Bayesian DCF, returns $9.00 on its own, implying -70.1% downside from the current price. See which stocks rank higher →

How Does ELMD Rank in Medical Devices?

Among 157 Medical Devices stocks, ELMD ranks #7 by Quality of Company score. CirclFi's QOC score of 9.0/10 evaluates 32 fundamental signals. A score of 9.0 places ELMD in the top tier.

See all Most Undervalued Medical Devices Stocks →

The Medical Devices sector introduces analytical considerations specific to biopharma enterprise businesses. For Electromed, Inc., metrics like patent cliff exposure provide important context that general-purpose valuation models may underweight.

Is ELMD a Value Trap?

CirclFi's Value Trap algorithm assigns ELMD a score of 28/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

10 of 13 models are active for Electromed, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Deep Alpha Valuation Engine, Electromed, Inc. scores 9.0 out of 10 on our 32-signal quality assessment, a elite rating that ranks among the highest-quality businesses in our coverage universe. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.

The gap between the most bullish and bearish model spans +138.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ELMD valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ELMD's 10 active models, average confidence is 56%. Moderate confidence indicates reasonable fit.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Electromed, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

TMDXTransMedics Group, Inc.QOC 9.2SYKStryker CorporationQOC 9.0UFPTUFP Technologies, Inc.QOC 9.2INSPInspire Medical Systems, Inc.QOC 9.0DXCMDexCom, Inc.QOC 9.2BSXBoston Scientific CorporationQOC 8.9LNSRLENSAR, Inc.QOC 7.1BBNXBeta Bionics, Inc.QOC 6.1TNONTenon Medical, Inc.QOC 5.0IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: TMDX · SYK · UFPT · INSP · DXCM · BSX · LNSR · BBNX · TNON · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to ELMD?

7 companies across all industries closest to ELMD’s Quality of Company score of 9.0/10.

EGANeGain CorporationQOC 9.0CDECoeur Mining, Inc.QOC 9.0RGLDRoyal Gold, Inc.QOC 9.1REPXRiley Exploration Permian, Inc.QOC 9.0OPLNOPENLANE, Inc.QOC 9.1CHKPCheck Point Software Technologies Ltd.QOC 9.0NVDANVIDIA CorporationQOC 10.0

Read investment analysis: EGAN · CDE · RGLD · REPX · OPLN · CHKP · NVDA

Where Does ELMD Sit in CirclFi's Medical Devices Rankings?

ELMD is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Electromed, Inc.’s Valuation?

What is Electromed, Inc.'s intrinsic value in 2026?

CirclFi puts Electromed, Inc. (ELMD)'s intrinsic value at $19.59 — the median of 10 independent model estimates as of 2026-08-27, ranging from $9.00 to $50.63. One component of that median, the Bayesian DCF, runs 10,000 Monte Carlo simulations with jump-diffusion and returns $9.00 on its own. The Quality of Company score is 9.0/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ELMD overvalued or undervalued right now?

At $30.14, 3 of 10 active models suggest ELMD may be undervalued, while 7 indicate potential overvaluation. The median of all 10 fair value estimates is $19.59, 35.0% below the current price of $30.14 — a consensus view that ELMD is overvalued. The assessment depends on which methodology best fits Electromed, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 9.0 mean for ELMD?

Electromed, Inc.'s QOC of 9.0/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores above 7 indicate strong fundamentals and disciplined management.

How many valuation models does CirclFi run on ELMD?

CirclFi analyzes ELMD with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 10 of 13 are active for this stock. Read the full methodology →

Which valuation models are most bullish and most bearish on ELMD?

Of the 10 models currently active on ELMD, Regime Cross-Sectional is the most bullish at $50.63 per share, and Bayesian DCF is the most bearish at $9.00. CirclFi's published fair value for ELMD is the median of that range, $19.59, not either extreme. The gap between the two ends equals 212% of the median — a wide spread, meaning the methods genuinely disagree and the median should carry less weight. Browse stocks by value-trap risk →

Is ELMD a value trap in 2026?

Electromed, Inc.'s Value Trap score is 28/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap.

Cite this analysis — “According to CirclFi’s 10-model valuation engine, Electromed, Inc. (ELMD) has a median fair value of $19.59 — 35.0% below the current price of $30.14 — as of 2026-08-27.” Source: circlfi.com/stock/ELMD/ · Methodology
Primary sources for this ELMD valuation
  • Financial statements: Electromed, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001488917) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ELMD as of ; valuations recomputed .

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 10 mathematical frameworks give you clarity on ELMD.

Unlock All 10 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access

6 models hidden for ELMD Unlock All 10 — $39/mo